THE DEAL, AT A GLANCE
From the announcementCyllene Therapeutics
01Who is involvedBacked by CEO Philippe ChambonFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedCyllene Therapeutics raised Series C, announced 2026-07-07From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersCyllene Therapeutics' $33M Series C is a below-median Healthcare & Life Sciences capital-allocation signal within an active trailing-30-day funding market, supporting…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Cyllene Therapeutics · Financing Record
Explore source-linked visual explanations for Cyllene Therapeutics. Unsupported claims are withheld while source review continues.
Record 7605 · Recorded date: 2026-07-07
Explore company records →